Qiagen NV (Qiagen NV) 3-Year Revenue Growth Rate : 2.20% (As of Dec. 2023)

View and export this data going back to 1996. Start your Free Trial

What is Qiagen NV 3-Year Revenue Growth Rate?

Qiagen NV's Revenue per Share for the three months ended in Dec. 2023 was $2.28.

During the past 12 months, Qiagen NV's average Revenue per Share Growth Rate was -8.40% per year. During the past 3 years, the average Revenue per Share Growth Rate was 2.20% per year. During the past 5 years, the average Revenue per Share Growth Rate was 7.60% per year. During the past 10 years, the average Revenue per Share Growth Rate was 6.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Qiagen NV was 36.20% per year. The lowest was -0.30% per year. And the median was 9.25% per year.

Competitive Comparison of Qiagen NV's 3-Year Revenue Growth Rate

For the Diagnostics & Research subindustry, Qiagen NV's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Qiagen NV's 3-Year Revenue Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Qiagen NV's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Qiagen NV's 3-Year Revenue Growth Rate falls into.

Qiagen NV 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Qiagen NV (NYSE:QGEN) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Qiagen NV 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Qiagen NV's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Qiagen NV (Qiagen NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Qiagen NV (NYSE:QGEN) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

EXAS NTRA CRL MEDP RVTY RDNT DGX SHC NEOG GH TMO DHR IQV XSWX:LONN IDXX A MTD ICLR ILMN WAT

Traded in Other Exchanges

1QGEN:Italy QIAd:UK 0RLT:UK QIA:Germany QIA:Germany QIA:Germany QIA:Germany QGEN:Austria

Address

Hulsterweg 82, Venlo, LI, NLD, 5912 PL

Website

https://www.qiagen.com

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (over 45% of 2022 sales), followed by EMEA (nearly 35%), and Asia-Pacific (nearly 20%).

Executives